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To clarify the relationship between variation in mtDNA and the development of cardiomyopathy (CM), the complete
sequences of mtDNAs of two brothers with dilated CM were compared with those of 181 patients who had CM
and with those of 168 control subjects. Five patients with CM shared a novel homoplasmic pointmutation (G12192A
tRNAHis), and all of them demonstrated the evolutionarily related D-loop sequence. The results suggest that this
novel mutation originated from the same ancestor and that its presence strongly predisposes carriers to CM.
DNA-based gene analysis has shown that more than half
of hypertrophic cardiomyopathy (HCM [MIM 192600])
cases are the result of sarcomeric disease (Geisterfer-
Lowrance et al. 1990; Spirito et al. 1997). However, in
the remaining cases of HCM—and in cases of dilated
cardiomyopathy (DCM) and of variable phenotype ex-
pression among members of the same family with a par-
ticular gene mutation (Graham and Owens 1999)—the
pathogenesis remains unknown. Meanwhile, mtDNA
mutation has emerged as a cause of hereditary cardio-
myopathy (CM) (Wallace 1992, 1999; Ozawa 1997).
Among several point mutations known to cause mito-
chondrial encephalomyopathy, frequent cardiac involve-
ment was reported in patients with encephalopathy who
have the A3243G transition mutation in mtDNA, which
causes MELAS (mitochondrial myopathy, encephalop-
athy, lactic acidosis, and strokelike episodes) (Goto et
al. 1990). A small but significant proportion (2.5%)
of patients with CM were found to have the A3243G
transition mutation without encephalomyopathy (au-
thors’ unpublished data). To identify unknown mtDNA
mutations causing CM, two brothers with maternally
inherited CM were assessed.
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A 60-year-old Japanese man who had reduced con-
traction of the left ventricle (LV) (percent fractional
shortening 20%–30%, by echocardiography) for 10
years was admitted for evaluation of his cardiac func-
tion. (His mother had died of congestive heart failure,
and his younger brother [age 56 years] had been treated
for acute exacerbation of DCM.) The echocardiography
and electrocardiogram (EKG)-gated cardiac magnetic
resonance imaging revealed a deformed LV cavity with
decreased contraction (Suzuki et al. 1999). Results of
the chest X-ray, EKG, cardiac catheterization, and cor-
onary angiography were normal, except for the presence
of diffuse hypokinesis of the LV wall (ejection fraction
51%). The endomyocardial biopsy specimen demon-
strated marked loss or disruption of sarcomeres and
massive accumulation of mitochondria of various sizes
(fig. 1). Direct sequencing of the entire mtDNAs ex-
tracted from the endomyocardial biopsy sample of the
elder brother and from white blood cells of both men
revealed that the brothers share a GrA substitution at
position 12192 in tRNAHis (MIM 590040). This mu-
tation is located 2 bp from the 3′ end of the TWC loop
of the tRNA. Because the mutation adds an A:T base
pair and shortens the loop itself, it may affect mito-
chondrial function.
Searching for other patients with the same mutation,
we screened 126 patients with HCM, 55 patients with
DCM, and 168 control subjects without cardiac disease.
After obtaining informed consent, we tested for single-
strand conformation polymorphism. We detected four
additional patients with the mutation. The first was a
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Figure 1 Electron-microscopic features of cardiomyocytes of the patient with the G12192A tRNAHis homoplasmic mutation. Mitochondria
of various sizes heterogeneously accumulated within a single cell, and the sarcomere structure was disrupted or totally lost. Lysosomes were
prominently accumulated at both sides of the nucleus. The round structure at the right of the nucleus has a double lumen and appears to be
a greatly enlarged mitochondrion. (Scale bar p 2 mm.)
patient with HCM who had been resuscitated after car-
diac arrest and whose mother and grandmother had died
suddenly of DCM. The second patient had asympto-
matic HCM; the third had DCM with frequent pre-
mature ventricular contractions; and the fourth had
DCM with heart failure. No control subject had the
mutation. To determine the risk of development of CM
in persons carrying this mutation, an odds ratio was
calculated from the G12192A frequency in patients with
CM and in controls. The modified formula with small
numbers of Woolf’s method (Schlesselman 1982) gave
an odds ratio of 10.5 (95% confidence interval 1.0–
110.0), indicating that persons with the G12192A mu-
tation have a significantly higher mean risk of developing
CM than do persons without the G12192A mutation.
All five subjects with the G12192A mutation showed
homoplasmy. Because homoplasmic mutation can be a
risk factor for slowly progressive disease (Wallace 2000),
we performed phylogenetic analysis of mtDNAs by the
neighbor-joining method (Saitou and Nei 1987) in the
PHYLIP (phylogeny inference package), version 3.5c
(Felsenstein 1993), using the 562-bp D-loop sequence
(Shoffner et al. 1993; Hutchin and Cortopassi 1995) in
the 5 patients with CM who had the G12192A mutation,
in 16 of the patients with CM who did not have the
mutation, and in 20 of the normal Asian individuals. To
our surprise, analysis of the noncoding D-loops revealed
that all patients with the G12192A mutation were re-
lated to one another and formed a single cluster in the
phylogenetic tree (fig. 2). Furthermore, these patients
with the G12192A mutation shared an ArT substitution
at position 16318 in the D-loop, which was not detected
in other patients with CM or in subjects without CM.
These findings strongly support the close evolutionary
relationship among the mtDNAs of the patients, as well
as a single origin of the G12192A mutation.
All five patients with the G12192A mutation showed
signs of cardiac abnormalities but no evidence of neuro-
logical abnormalities or of diabetes, which usually ap-
pear (singly or together) in patients with MELAS due to
the heteroplasmic A3243G mutation (MIM 540000)
and may also appear in a small percentage of patients
with CM (Ozawa 1997; Wallace 1999). In contrast to
homoplasmy of mtDNAs, heteroplasmic mutations in
mitochondrial genes are evolutionarily unrelated and
cause severe clinical symptoms in children and young
adults (Wallace 2000). Taken together with this ho-
moplasmic mutation and the tight clonal evolutionary
relationship of the mtDNAs carrying the mutation, this
particular transition mutation belongs to a class of mi-
tochondrial disorders that are characterized by late onset
and that therefore escape negative selection (e.g.,
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Figure 2 Phylogenetic analysis of mitochondrial D-loop se-
quence in patients with CM who have the G12192A mutation, in other
patients with CM, and in control subjects. The phylogenetic tree was
constructed by the neighbor-joining method in the PHYLIP package
(Felsenstein 1993). White circlesp subjects without CM; green circles
p patients with CM; and red circles p patients with both CM and
the G12192A mutation.
A4336G [late-onset Alzheimer disease; Hutchin and
Cortopassi 1995] or A1555G [maternally inherited sus-
ceptibility to antibiotic-induced deafness; Prezant et al.
1993]).
We have investigated in mtDNA a novel point mu-
tation that is associated with cardiomyopathy. There-
fore, this entity does not belong to any mutations known
to be associated with CM. It is not connected with id-
iopathic mitochondrial DCM (MIM 510000), because
that mutation is restricted to DCM, whereas the point
mutation of the present study can result in either DCM
and HCM.
Morphological alteration of cardiac mitochondria and
structural change, of the mutant tRNAHis, combined
with the unique D-loop sequence therefore suggest that
patients with the G12192A mutation may constitute a
group with genetically determined high risk for the grad-
ual development of HCM or DCM. Screening of blood
samples of patients with CM, for homoplasmic mutation
in mtDNAs, promises detection of all patients with the
mutation and therefore may be useful both for early
diagnosis and for prevention of a potentially lethal
disease.
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